Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_49833 | 125 | 2.61 | Mlig455_070010 | Neo: - Age: - |
Mlig455_070010 {REF} {Length: 4603} {RNA1509_22628} {RNA1310_1605.1} {RNA815_22526} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.246 | 1.876 | 0.55845 | 1.00000 | |
RegionR2 | -1.248 | 1.876 | 0.99387 | 1.00000 | |
RegionR3 | 0.056 | 1.876 | 0.83420 | 1.00000 | |
RegionR4 | 1.003 | 1.876 | 0.42597 | 0.75387 | |
RegionR5 | -0.962 | 1.876 | 0.98927 | 1.00000 | |
RegionR6 | 0.62 | 1.876 | 0.55201 | 1.00000 | |
RegionR7 | 2.176 | 1.876 | 0.04603 | 0.41316 | |
RegionR8 | 1.601 | 1.876 | 0.32161 | 0.95564 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 5.724 | 1.876 | 0.22000 | 0.95484 | |
RegenerationR2 | 0.851 | 1.876 | 0.26832 | 0.71408 | |
RegenerationR3 | 0.744 | 1.876 | 0.40833 | 0.80732 | |
RegenerationR4 | -0.353 | 1.876 | 0.70856 | 0.95684 | |
RegenerationR5 | 0.924 | 1.876 | 0.30314 | 0.73045 | |
RegenerationR6 | -0.786 | 1.876 | 0.38148 | 0.72234 | |
RegenerationBL | -0.798 | 1.876 | 0.43791 | 0.80533 | |
RegenerationTP | 0.131 | 1.876 | 0.91589 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_49833 | 125 | 2.61 | Mlig455_070010 | Neo: - Age: - |
4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_070010 {REF} {Length: 4603} {RNA1509_22628} {RNA1310_1605.1} {RNA815_22526} | |
2. | MligTC455_22230 | 170 | 3.54 | Mlig455_013703, Mlig455_013720 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.137/0.00004 |
2.642 | - | - | 0.953 | 0.785 | - | 0.904 | Mlig455_013703 {REF} {Length: 2025} {RNA1509_49155} {RNA1310_23836, RNA1509_49155} {RNA1509_49155, RNA815_28676} Mlig455_013720 {REF} {Length: 2031} {RNA1509_49155} {RNA1310_23836} {RNA815_28676} |
|
3. | MligTC455_49832 | 187 | 3.89 | Mlig455_016849, Mlig455_065922 | Neo: - Age: - |
SESTD1 | 2.561 | - | - | - | 0.767 | 0.835 | 0.959 | Mlig455_016849 {REF} {Length: 4773} {Human: ENSG00000187231, SESTD1, SEC14 and spectrin domain containing 1, [Score=55.5, Expect=7e-07]} {Mouse: ENSMUSG00000031442, Mcf2l, mcf.2 transforming sequence-like, [Score=60.1, Expect=2e-08]} {Smed: dd_Smed_v6_12952_0_1, dd_Smed_v6_12952_0_1, [Score=121, Expect=6e-28]} {RNA1509_22628} {RNA1310_1605.1} {RNA815_22526} Mlig455_065922 {REF} {Length: 4792} {Human: ENSG00000187231, SESTD1, SEC14 and spectrin domain containing 1, [Score=53.1, Expect=3e-06]} {Mouse: ENSMUSG00000031442, Mcf2l, mcf.2 transforming sequence-like, [Score=54.3, Expect=1e-06]; ENSMUSG00000042272, Sestd1, SEC14 and spectrin domains 1, [Score=53.5, Expect=2e-06]} {Smed: dd_Smed_v6_12952_0_1, dd_Smed_v6_12952_0_1, [RH, Score=129, Expect=2e-30]} {RNA1509_22628} {RNA1310_1605.1, RNA1509_22628} {RNA1509_22628, RNA815_22526} |
4. | MligTC455_15007 | 81 | 1.69 | Mlig455_044466 | Neo: - Age: - Region-enriched R7: 4.691/0.00001 |
1.784 | - | - | 0.964 | - | - | 0.820 | Mlig455_044466 {REF} {Length: 470} {NoTransDecoderORF} {RNA1310_96814} | |
5. | MligTC455_26662 | 78 | 1.63 | Mlig455_061366, Mlig455_061393 | Neo: - Age: logFC(26M/2M)=-0.528 |
PLEKHG7 | 1.78 | - | - | 0.950 | - | - | 0.830 | Mlig455_061366 {REF} {Length: 4952} {Pfam: RhoGEF domain [PF00621.22, score=76.5]; Pleckstrin homology domain [PF16652.7, score=44.5]; Pleckstrin homology domain [PF15405.8, score=20.6]} {Human: ENSG00000187510, PLEKHG7, pleckstrin homology and RhoGEF domain containing G7, [Score=234, Expect=2e-64]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=119, Expect=1e-26]} {Dmel: FBgn0261556, CG42674, [Score=101, Expect=4e-21]} {Celegans: WBGene00022391, Y95B8A.12, [RH, Score=313, Expect=8e-93]} {Smed: dd_Smed_v6_20050_0_1, dd_Smed_v6_20050_0_1, [RH, Score=660, Expect=0.0]} {RNA1509_30198} {RNA1310_1409.1, RNA1509_30198} {RNA1509_30198, RNA815_382} Mlig455_061393 {REF} {Length: 4339} {Pfam: RhoGEF domain [PF00621.22, score=77.2]; Pleckstrin homology domain [PF16652.7, score=33.5]; Pleckstrin homology domain [PF15405.8, score=19.3]} {Human: ENSG00000187510, PLEKHG7, pleckstrin homology and RhoGEF domain containing G7, [Score=229, Expect=6e-63]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=107, Expect=6e-23]} {Dmel: FBgn0261556, CG42674, [Score=94.4, Expect=4e-19]} {Celegans: WBGene00022391, Y95B8A.12, [RH, Score=310, Expect=8e-93]} {Smed: dd_Smed_v6_20050_0_1, dd_Smed_v6_20050_0_1, [Score=644, Expect=0.0]} {RNA1509_30198} {RNA1310_1409.1} {RNA815_382} |
6. | MligTC455_42059 | 387 | 8.07 | Mlig455_062377 | Neo: - |
GFAP | 1.749 | - | - | - | - | 0.794 | 0.955 | Mlig455_062377 {REF} {Length: 3972} {Pfam: Intermediate filament protein [PF00038.23, score=152.8]; Myosin tail [PF01576.21, score=25.9]; Protein SOGA [PF11365.10, score=20.3]} {Human: ENSG00000131095, GFAP, glial fibrillary acidic protein, [Score=109, Expect=5e-25]; ENSG00000113368, LMNB1, lamin B1, [Score=105, Expect=1e-23]; ENSG00000160789, LMNA, lamin A/C, [Score=105, Expect=3e-23]} {Mouse: ENSMUSG00000026208, Des, desmin, [Score=112, Expect=6e-26]; ENSMUSG00000020932, Gfap, glial fibrillary acidic protein, [Score=107, Expect=1e-24]} {Dmel: FBgn0010397, LamC, Lamin C, [Score=140, Expect=3e-35]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [Score=239, Expect=1e-71]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [Score=284, Expect=1e-88]} {RNA1509_17658, RNA1509_42622, RNA1509_50182} {RNA1310_10237.1, RNA1509_42622, RNA1509_50182} {RNA1509_42622, RNA1509_50182, RNA815_9230.1} |
7. | MligTC455_15927 | 157 | 3.26 | Mlig455_032763 | Neo: - Age: logFC(26M/2M)=1.700 |
1.726 | - | - | - | 0.772 | - | 0.954 | Mlig455_032763 {REF} {Length: 628} {RNA1509_55349} {RNA1310_76770, RNA1509_55349} {RNA1509_55349, RNA815_39882} | |
8. | MligTC455_24113 | 417 | 8.68 | Mlig455_051239 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.866/0.00000 |
0.981 | - | - | - | - | - | 0.981 | Mlig455_051239 {REF} {Length: 4276} {NoTransDecoderORF} {RNA1509_23461} {RNA1310_60603} {RNA815_48925} | |
9. | MligTC455_29014 | 26 | 0.54 | Mlig455_005715 | Neo: - Age: - |
RXFP1 | 0.977 | - | - | - | - | 0.977 | - | Mlig455_005715 {REF} {Length: 6183} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=91.2]; CUB domain [PF00431.22, score=57.2]; Lectin C-type domain [PF00059.23, score=33.0]; Leucine rich repeat [PF13855.8, score=20.7]} {Human: ENSG00000171509, RXFP1, relaxin family peptide receptor 1, [Score=180, Expect=1e-45]} {Mouse: ENSMUSG00000053368, Rxfp2, relaxin/insulin-like family peptide receptor 2, [Score=175, Expect=2e-44]; ENSMUSG00000034009, Rxfp1, relaxin/insulin-like family peptide receptor 1, [Score=168, Expect=3e-42]} {Dmel: FBgn0039354, Lgr3, Leucine-rich repeat-containing G protein-coupled receptor 3, [Score=140, Expect=2e-33]} {Celegans: WBGene00008239, fshr-1, FSHR (Mammalian follicle stimulating hormone receptor) homolog; Leucine-rich repeat-containing G protein-coupled receptor, [RH, Score=124, Expect=3e-28]} {Smed: dd_Smed_v6_17598_0_1, dd_Smed_v6_17598_0_1, [Score=305, Expect=1e-83]} {RNA1310_40598} {RNA815_31685} |
10. | MligTC455_39196 | 145 | 3.02 | Mlig455_066396 | Neo: - Age: - |
PINK1 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_066396 {REF} {Length: 3123} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=58.8]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=30.3]} {Human: ENSG00000158828, PINK1, PTEN induced putative kinase 1, [RH, Score=122, Expect=3e-29]} {Mouse: ENSMUSG00000028756, Pink1, PTEN induced putative kinase 1, [RH, Score=125, Expect=2e-30]} {Dmel: FBgn0029891, Pink1, PTEN-induced putative kinase 1, [RH, Score=107, Expect=2e-24]} {Celegans: WBGene00003247, mig-15, Serine/threonine-protein kinase mig-15, [Score=55.8, Expect=5e-08]} {Smed: dd_Smed_v6_12125_0_1, dd_Smed_v6_12125_0_1, [Score=57.0, Expect=6e-09]} {RNA1509_22713, RNA1509_31782, RNA1509_6340} {RNA1310_11261.1, RNA1509_22713, RNA1509_31782, RNA1509_6340} {RNA1509_22713, RNA1509_31782, RNA1509_6340, RNA815_20404} |
11. | MligTC455_51186 | 86 | 1.79 | Mlig455_012864 | Neo: - Age: Up-Down-Down |
CLCN1 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_012864 {REF} {Length: 4861} {Pfam: Voltage gated chloride channel [PF00654.22, score=186.4]} {Human: ENSG00000188037, CLCN1, chloride voltage-gated channel 1, [Score=179, Expect=1e-45]} {Mouse: ENSMUSG00000029862, Clcn1, chloride channel, voltage-sensitive 1, [Score=175, Expect=2e-44]} {Dmel: FBgn0051116, ClC-a, Chloride channel-a, [Score=167, Expect=6e-42]} {Celegans: WBGene00000530, clh-3, Chloride channel protein clh-3, [Score=209, Expect=3e-55]} {Smed: dd_Smed_v6_12606_0_1, dd_Smed_v6_12606_0_1, [RH, Score=181, Expect=7e-47]} {RNA1310_30491} {RNA815_34327} |
12. | MligTC455_18076 | 90 | 1.88 | Mlig455_006853 | Neo: - Age: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_006853 {REF} {Length: 288} {NoTransDecoderORF} {RNA1310_48189} {RNA815_23999} | |
13. | MligTC455_28914 | 147 | 3.07 | Mlig455_025545 | Neo: - Age: - Region-enriched R7: 3.856/0.00000 |
SCNN1B | 0.973 | - | - | 0.973 | - | - | - | Mlig455_025545 {REF} {Length: 1051} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=51.5]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=52.8, Expect=3e-08]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=49.3, Expect=3e-07]; ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=48.9, Expect=4e-07]} {Celegans: WBGene00000950, deg-1, Degenerin deg-1, [Score=53.9, Expect=4e-09]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=48.1, Expect=1e-07]} {RNA1310_15213} {RNA815_42777} |
14. | MligTC455_40781 | 153 | 3.2 | Mlig455_024109, Mlig455_063982 | Neo: - Age: - |
0.967 | - | - | - | - | - | 0.967 | Mlig455_024109 {REF} {Length: 1081} {RNA1509_16458} {RNA1310_43664.1, RNA1509_16458} {RNA1509_16458, RNA815_23166} Mlig455_063982 {REF} {Length: 3562} {RNA1509_16458} {RNA1310_30070} {RNA815_23166} |
|
15. | MligTC455_42720 | 246 | 5.13 | Mlig455_024695, Mlig455_024719 | Neo: - |
CHRNA3 | 0.962 | - | - | - | - | - | 0.962 | Mlig455_024695 {REF} {Length: 2853} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=188, Expect=7e-54]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=186, Expect=3e-53]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=187, Expect=8e-54]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=187, Expect=1e-53]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=185, Expect=2e-53]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=179, Expect=9e-51]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=194, Expect=4e-56]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=179, Expect=2e-50]} {Smed: dd_Smed_v6_2019_0_1, dd_Smed_v6_2019_0_1, [Score=314, Expect=2e-103]} {RNA1509_30530} {RNA1310_16567} {RNA815_2979.1} Mlig455_024719 {REF} {Length: 3783} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=80.8]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=8e-55]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=190, Expect=3e-54]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=193, Expect=2e-55]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=192, Expect=6e-55]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=187, Expect=1e-53]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=187, Expect=2e-53]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=196, Expect=6e-56]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=179, Expect=5e-50]} {Smed: dd_Smed_v6_2019_0_1, dd_Smed_v6_2019_0_1, [Score=316, Expect=1e-103]} {RNA1509_30530} {RNA1310_16567, RNA1509_30530} {RNA1509_30530, RNA815_2979.1} |
16. | MligTC455_28994 | 66 | 1.38 | Mlig455_030538 | Neo: - Age: Up-Down-Up |
SIX1 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_030538 {REF} {Length: 3445} {TRANSSPLICED} {Pfam: Transcriptional regulator, SIX1, N-terminal SD domain [PF16878.7, score=146.9]; Homeodomain [PF00046.31, score=55.9]; Homeobox KN domain [PF05920.13, score=48.0]} {Human: ENSG00000126778, SIX1, SIX homeobox 1, [Score=313, Expect=1e-103]; ENSG00000170577, SIX2, SIX homeobox 2, [Score=307, Expect=4e-101]} {Mouse: ENSMUSG00000051367, Six1, sine oculis-related homeobox 1, [Score=313, Expect=9e-104]; ENSMUSG00000024134, Six2, sine oculis-related homeobox 2, [Score=307, Expect=2e-101]} {Dmel: FBgn0003460, so, sine oculis, [Score=303, Expect=3e-98]} {Celegans: WBGene00000454, ceh-33, Homeobox protein ceh-33, [RH, Score=246, Expect=3e-78]} {Smed: dd_Smed_v6_15436_0_1, dd_Smed_v6_15436_0_1, [RH, Score=328, Expect=2e-107]} {RNA1509_55511} {RNA1310_27700} {RNA815_16067} |
17. | MligTC455_39689 | 1017 | 21.19 | Mlig455_065151 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_065151 {REF} {Length: 3308} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=32.4]; Prokaryotic RING finger family 4 [PF14447.8, score=22.8]} {Dmel: FBgn0015247, Diap2, Death-associated inhibitor of apoptosis 2, [Score=46.6, Expect=1e-05]} {Smed: dd_Smed_v6_2453_0_2, dd_Smed_v6_2453_0_2, [RH, Score=50.8, Expect=2e-08]} {RNA1509_38551} {RNA1310_22124.1} {RNA815_14106} | |
18. | MligTC455_48055 | 271 | 5.65 | Mlig455_059256 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_059256 {REF} {Length: 4894} {Pfam: PX domain [PF00787.26, score=33.5]} {RNA1509_29567, RNA1509_47008} {RNA1310_1542.1, RNA1509_47008} {RNA1509_47008, RNA815_21449} | |
19. | MligTC455_21058 | 197 | 4.11 | Mlig455_012541 | Neo: Int S/G2/M Age: - |
PPAT | 0.959 | - | - | - | - | 0.959 | - | Mlig455_012541 {REF} {Length: 5957} {TRANSSPLICED} {Pfam: Glutamine amidotransferase domain [PF13522.8, score=52.7]; Glutamine amidotransferase domain [PF13537.8, score=48.5]; Ring finger domain [PF13639.8, score=39.7]; 3' exoribonuclease family, domain 2 [PF03725.17, score=32.3]; 3' exoribonuclease family, domain 1 [PF01138.23, score=31.9]; RING-H2 zinc finger domain [PF12678.9, score=26.5]; Phosphoribosyl transferase domain [PF00156.29, score=26.4]; RING-type zinc-finger [PF13445.8, score=25.8]; zinc-RING finger domain [PF14634.8, score=24.6]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.6]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=22.2]; Glutamine amidotransferases class-II [PF13230.8, score=20.4]; Domain of unknown function (DUF4620) [PF15399.8, score=20.4]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=20.2]} {Human: ENSG00000128059, PPAT, phosphoribosyl pyrophosphate amidotransferase, [RH, Score=530, Expect=3e-173]} {Mouse: ENSMUSG00000029246, Ppat, phosphoribosyl pyrophosphate amidotransferase, [RH, Score=529, Expect=3e-173]} {Dmel: FBgn0041194, Prat2, Phosphoribosylamidotransferase 2, [RH, Score=505, Expect=5e-164]} {Celegans: WBGene00011407, ppat-1, Amidophosphoribosyltransferase, [RH, Score=399, Expect=2e-125]} {Smed: dd_Smed_v6_10667_0_1, dd_Smed_v6_10667_0_1, [RH, Score=512, Expect=2e-167]} {RNA1509_41149} {RNA1310_4226.1} {RNA815_5739} |
20. | MligTC455_48934 | 145 | 3.02 | Mlig455_008024 | Neo: - Age: Down-Up-Up |
SLC2A1 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_008024 {REF} {Length: 2656} {Pfam: Sugar (and other) transporter [PF00083.26, score=316.8]; Major Facilitator Superfamily [PF07690.18, score=87.4]} {Human: ENSG00000117394, SLC2A1, solute carrier family 2 member 1, [Score=320, Expect=2e-102]; ENSG00000059804, SLC2A3, solute carrier family 2 member 3, [Score=310, Expect=1e-98]} {Mouse: ENSMUSG00000028645, Slc2a1, solute carrier family 2 (facilitated glucose transporter), member 1, [Score=320, Expect=1e-102]} {Dmel: FBgn0264574, Glut1, Glucose transporter 1, [Score=287, Expect=5e-89]} {Celegans: WBGene00019207, fgt-1, Facilitated glucose transporter protein 1, [Score=236, Expect=1e-70]} {Smed: dd_Smed_v6_5447_0_1, dd_Smed_v6_5447_0_1, [RH, Score=416, Expect=3e-140]} {RNA1509_46818} {RNA1310_8373.1} {RNA815_18227} |
21. | MligTC455_36882 | 118 | 2.45 | Mlig455_040028 | Neo: Int S/G2/M Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_040028 {REF} {Length: 3355} {RNA1509_39805} {RNA1310_24031, RNA1509_39805} {RNA1509_39805, RNA815_10951.1} | |
22. | MligTC455_42191 | 379 | 7.9 | Mlig455_012126, Mlig455_029001 | Neo: - Age: Down-Up-Up |
0.958 | - | - | - | - | - | 0.958 | Mlig455_012126 {REF} {Length: 1565} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=53.1, Expect=4e-09]} {RNA1310_28170} {RNA815_25748} Mlig455_029001 {REF} {Length: 1721} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.8, Expect=6e-09]} {RNA1509_52997} {RNA1310_28170} {RNA815_25748} |
|
23. | MligTC455_23836 | 510 | 10.62 | Mlig455_037024 | Neo: - Age: logFC(26M/2M)=0.239 |
EEF2K | 0.956 | - | - | - | - | 0.956 | - | Mlig455_037024 {REF} {Length: 5089} {Pfam: Alpha-kinase family [PF02816.20, score=193.9]} {Human: ENSG00000103319, EEF2K, eukaryotic elongation factor 2 kinase, [RH, Score=446, Expect=3e-145]; ENSG00000284161, EEF2K, eukaryotic elongation factor 2 kinase, [RH, Score=446, Expect=4e-145]} {Mouse: ENSMUSG00000035064, Eef2k, eukaryotic elongation factor-2 kinase, [RH, Score=437, Expect=3e-142]} {Celegans: WBGene00001160, efk-1, Eukaryotic elongation factor 2 kinase, [RH, Score=325, Expect=3e-99]} {Smed: dd_Smed_v6_9576_0_1, dd_Smed_v6_9576_0_1, [RH, Score=413, Expect=1e-135]} {RNA1509_39820, RNA1509_41897} {RNA1310_5515.3, RNA1509_39820, RNA1509_41897} {RNA1509_39820, RNA1509_41897, RNA815_2668.1} |
24. | MligTC455_24267 | 26 | 0.54 | Mlig455_005114, Mlig455_005116, Mlig455_005118 | Neo: - Age: - |
CHRNA7 | 0.956 | - | - | - | 0.956 | - | - | Mlig455_005114 {REF} {Length: 1666} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=114.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=64.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=146, Expect=3e-38]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=3e-37]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=144, Expect=9e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=138, Expect=9e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=134, Expect=8e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=1e-34]} {RNA1509_43533} {RNA1310_21349.1} {RNA815_22406} Mlig455_005116 {REF} {Length: 1663} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=114.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=63.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=146, Expect=3e-38]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=3e-37]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=144, Expect=8e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=138, Expect=9e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=134, Expect=9e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=1e-34]} {RNA1509_43533} {RNA1310_21349.1} {RNA815_22406} Mlig455_005118 {REF} {Length: 1662} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=114.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=63.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=146, Expect=3e-38]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=3e-37]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=144, Expect=8e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=138, Expect=9e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=134, Expect=9e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=1e-34]} {RNA1509_43533} {RNA1310_21349.1} {RNA815_22406} |
25. | MligTC455_25776 | 220 | 4.59 | Mlig455_000479, Mlig455_024867 | Neo: - Age: - |
0.956 | - | - | 0.956 | - | - | - | Mlig455_000479 {REF} {Length: 548} {Pfam: PHD-finger [PF00628.31, score=27.6]} {RNA1310_79789} Mlig455_024867 {REF} {Length: 1776} {Pfam: PHD-finger [PF00628.31, score=25.7]} {RNA1310_46465} |
|
26. | MligTC455_29533 | 234 | 4.88 | Mlig455_038058 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_038058 {REF} {Length: 5161} {TRANSSPLICED} {Pfam: Mab-21 protein [PF03281.16, score=43.8]} {RNA1509_14178, RNA1509_25948, RNA1509_39951, RNA1509_43236, RNA1509_47099, RNA1509_51073, RNA1509_57888, RNA1509_8943} {RNA1310_4721, RNA1509_14178, RNA1509_39951, RNA1509_43236, RNA1509_47099, RNA1509_51073, RNA1509_57888, RNA1509_8943} {RNA1509_14178, RNA1509_39951, RNA1509_43236, RNA1509_47099, RNA1509_51073, RNA1509_57888, RNA1509_8943, RNA815_2426.1} | |
27. | MligTC455_12923 | 42 | 0.88 | Mlig455_008474 | Neo: - Age: - |
EPB41L2 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_008474 {REF} {Length: 3609} {Pfam: FERM N-terminal domain [PF09379.12, score=52.0]; FERM C-terminal PH-like domain [PF09380.12, score=39.9]; FERM central domain [PF00373.20, score=30.9]} {Human: ENSG00000079819, EPB41L2, erythrocyte membrane protein band 4.1 like 2, [Score=196, Expect=1e-51]; ENSG00000088367, EPB41L1, erythrocyte membrane protein band 4.1 like 1, [Score=187, Expect=2e-48]; ENSG00000082397, EPB41L3, erythrocyte membrane protein band 4.1 like 3, [Score=187, Expect=7e-49]} {Mouse: ENSMUSG00000024044, Epb41l3, erythrocyte membrane protein band 4.1 like 3, [Score=189, Expect=1e-49]; ENSMUSG00000027624, Epb41l1, erythrocyte membrane protein band 4.1 like 1, [Score=185, Expect=4e-48]; ENSMUSG00000019978, Epb41l2, erythrocyte membrane protein band 4.1 like 2, [Score=183, Expect=3e-47]; ENSMUSG00000028906, Epb41, erythrocyte membrane protein band 4.1, [Score=180, Expect=2e-46]} {Dmel: FBgn0010434, cora, coracle, [Score=187, Expect=9e-50]} {Celegans: WBGene00001488, frm-1, FERM domain (Protein4.1-ezrin-radixin-moesin) family, [Score=147, Expect=1e-36]} {Smed: dd_Smed_v6_2825_0_1, dd_Smed_v6_2825_0_1, [Score=189, Expect=7e-50]} {RNA1509_17087} {RNA1310_13598.1} {RNA815_9400.1} |
28. | MligTC455_16490 | 190 | 3.95 | Mlig455_050433 | Neo: - Age: - |
ADO | 0.953 | - | - | - | - | 0.953 | - | Mlig455_050433 {REF} {Length: 2970} {TRANSSPLICED} {Pfam: PCO_ADO [PF07847.14, score=155.2]} {Human: ENSG00000181915, ADO, 2-aminoethanethiol dioxygenase, [RH, Score=121, Expect=1e-32]} {Mouse: ENSMUSG00000116486, Ado, 2-aminoethanethiol (cysteamine) dioxygenase, [RH, Score=124, Expect=5e-34]; ENSMUSG00000057134, Ado, 2-aminoethanethiol (cysteamine) dioxygenase, [RH, Score=124, Expect=5e-34]} {Dmel: FBgn0035839, CG7550, [RH, Score=109, Expect=8e-29]} {Celegans: WBGene00021750, Y50D4C.6, [Score=45.8, Expect=8e-06]} {Smed: dd_Smed_v6_6833_0_1, dd_Smed_v6_6833_0_1, [RH, Score=215, Expect=1e-69]} {RNA1509_36208, RNA1509_48961} {RNA1310_34291, RNA1509_36208, RNA1509_48961} {RNA1509_36208, RNA1509_48961, RNA815_17054} |
29. | MligTC455_40018 | 295 | 6.15 | Mlig455_037646, Mlig455_069914 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.048 Region-enriched R8: 4.445/0.00001 |
AC243734.1, CHRNA2 | 0.951 | - | - | 0.951 | - | - | - | Mlig455_037646 {REF} {Length: 2101} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=46.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=27.0]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=68.9, Expect=6e-12]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=65.5, Expect=8e-11]} {Mouse: ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=75.5, Expect=3e-14]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=73.2, Expect=2e-13]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=82.8, Expect=9e-17]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=71.2, Expect=4e-13]} {Smed: dd_Smed_v6_8486_0_1, dd_Smed_v6_8486_0_1, [Score=78.2, Expect=2e-15]} {RNA1509_50033} {RNA1310_22440} {RNA815_15508} Mlig455_069914 {REF} {Length: 3748} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=68.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=60.3]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=108, Expect=5e-25]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=108, Expect=9e-25]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=108, Expect=5e-25]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=107, Expect=1e-24]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=99.4, Expect=5e-22]} {Celegans: WBGene00000951, deg-3, Acetylcholine receptor subunit alpha-type deg-3, [Score=94.0, Expect=3e-20]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=113, Expect=7e-27]} {RNA1509_50033} {RNA1310_16096, RNA1509_50033} {RNA1509_50033, RNA815_15508} |
30. | MligTC455_48933 | 111 | 2.31 | Mlig455_007917 | Neo: - Age: - |
SLC2A1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_007917 {REF} {Length: 2718} {Pfam: Sugar (and other) transporter [PF00083.26, score=295.1]; Major Facilitator Superfamily [PF07690.18, score=85.8]} {Human: ENSG00000117394, SLC2A1, solute carrier family 2 member 1, [Score=299, Expect=9e-94]; ENSG00000059804, SLC2A3, solute carrier family 2 member 3, [Score=296, Expect=7e-93]} {Mouse: ENSMUSG00000028645, Slc2a1, solute carrier family 2 (facilitated glucose transporter), member 1, [Score=299, Expect=6e-94]} {Dmel: FBgn0264574, Glut1, Glucose transporter 1, [Score=268, Expect=3e-81]} {Celegans: WBGene00019207, fgt-1, Facilitated glucose transporter protein 1, [Score=219, Expect=6e-64]} {Smed: dd_Smed_v6_5447_0_1, dd_Smed_v6_5447_0_1, [Score=374, Expect=4e-123]} {RNA1509_40120} {RNA1310_8373.1} {RNA815_18227} |
31. | MligTC455_11556 | 57 | 1.19 | Mlig455_002230 | Neo: - Age: logFC(26M/2M)=-0.375 |
0.95 | - | - | - | - | 0.950 | - | Mlig455_002230 {REF} {Length: 1911} {RNA1509_54456, RNA1509_57197} {RNA1310_17112, RNA1509_54456, RNA1509_57197} {RNA1509_54456, RNA1509_57197, RNA815_6319.1} | |
32. | MligTC455_44208 | 1187 | 24.73 | Mlig455_034393 | Neo: - Age: Down-Down-Up Region-enriched R4: 2.702/0.04491 |
0.95 | - | - | - | - | 0.950 | - | Mlig455_034393 {REF} {Length: 671} {RNA1509_3491} {RNA1310_46443.1} {RNA815_27422} | |
33. | MligTC455_50257 | 215 | 4.48 | Mlig455_011262 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_011262 {REF} {Length: 864} {NoTransDecoderORF} {RNA1310_36714.1} {RNA815_32855.1} |